ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

NCT01423175 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
MDS

Interventions

DRUG: Clofarabine, ara-C
DRUG: FLAMSA

Sponsor

Hannover Medical School

Collaborators

[object Object]